Shares of FibroGen, Inc. (NASDAQ:FGEN – Get Free Report) have earned an average recommendation of “Reduce” from the six analysts that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell rating and four have issued a hold rating on the company. The average 1-year price objective among brokerages […]
FibroGen, Inc. (NASDAQ:FGEN – Get Free Report) has received a consensus recommendation of “Reduce” from the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation and four have issued a hold recommendation on the company. The average 12 month price […]
Shares of FibroGen, Inc. (NASDAQ:FGEN – Get Free Report) have received a consensus rating of “Reduce” from the six ratings firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell rating and four have given a hold rating to the company. The average 1 year price objective […]
Shares of FibroGen, Inc. (NASDAQ:FGEN – Get Free Report) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $1.07 and traded as low as $0.74. FibroGen shares last traded at $0.75, with a volume of 2,325,034 shares traded. Analyst Ratings Changes […]
StockNews.com began coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a research note released on Friday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. FibroGen Stock Performance Shares of NASDAQ:FGEN opened at $0.62 on Friday. FibroGen has a 12-month low of $0.33 and a 12-month high of $25.69. The […]